Associations - Male Breast Cancer

HR positive + HER-2 negative HR positive + HER-2 negative	Male Breast Cancer Male Breast Cancer	tamoxifen Sensitive: A2 - Guideline tamoxifen Sensitive : A2
No biomarker No biomarker	Male Breast Cancer Male Breast Cancer	HER2 inhibitor Sensitive: A2 - Guideline HER2 inhibitor Sensitive : A2
HR positive + HER-2 negative HR positive + HER-2 negative	Male Breast Cancer Male Breast Cancer	Aromatase inhibitor + GnRH inhibitor Sensitive: A2 - Guideline Aromatase inhibitor + GnRH inhibitor Sensitive : A2
HR positive + HER-2 negative HR positive + HER-2 negative	Male Breast Cancer Male Breast Cancer	fulvestrant Sensitive: A2 - Guideline fulvestrant Sensitive : A2
HR positive HR positive	Male Breast Cancer Male Breast Cancer	Aromatase inhibitor Sensitive: A2 - Guideline Aromatase inhibitor Sensitive : A2
HR positive HR positive	Male Breast Cancer Male Breast Cancer	tamoxifen Sensitive: A2 - Guideline tamoxifen Sensitive : A2
ER positive ER positive	Male Breast Cancer Male Breast Cancer	tamoxifen Sensitive: A2 - Guideline tamoxifen Sensitive : A2

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and